
KYPROLIS
60mgKYPROLIS60mg
KYPROLIS (Carfilzomib) 60mg is a second-generation irreversible proteasome inhibitor for relapsed or refractory multiple myeloma.
Key Benefits
- Nearly doubled PFS vs Velcade in ENDEAVOR (18.7 vs 9.4 months)
- Superior OS: 47.6 vs 40.0 months
- Dramatically lower neuropathy (6% vs 32%)
- KRd regimen: 87-97% ORR — NCCN Category 1
- Once-weekly option (ARROW trial)
Contact Us for Pricing
Get a written quote against a prescription within 24 hours for KYPROLIS 60mg. Our team is available 24/7.
Direct line: +44 7429 917553
Prescription required
We do not proceed without one
Licensed Türkiye channels
İTS serial-traceable by karekod
Delivered in person
Not shipped by courier
Written reply
Quote within 24 hours
How KYPROLIS Works
Carfilzomib irreversibly binds to the 20S proteasome chymotrypsin-like activity (β5 subunit), blocking ubiquitin-mediated protein degradation. This causes accumulation of misfolded/damaged proteins, triggering ER stress, unfolded protein response, and ultimately apoptosis in myeloma cells.
About KYPROLIS 60mg
KYPROLIS (Carfilzomib) 60mg by Amgen is a breakthrough second-generation proteasome inhibitor that irreversibly binds to the 20S proteasome. The landmark ENDEAVOR trial demonstrated Kyprolis+Dex nearly doubled PFS vs Velcade+Dex (18.7 vs 9.4 months, HR=0.53) with superior OS (47.6 vs 40.0 months) and dramatically lower peripheral neuropathy (6% vs 32%). The KRd regimen (Kyprolis+Revlimid+dexamethasone) achieves 87-97% ORR and is an NCCN Category 1 preferred regimen. Working through licensed Turkish pharmacy channels, we provide authentic Amgen KYPROLIS with complete cold chain handling and a written quote against a prescription, usually within 24 hours.
Common Uses
- Relapsed or refractory multiple myeloma
- KRd regimen (with Lenalidomide + Dexamethasone)
- Kd regimen (with Dexamethasone alone)
- Frontline multiple myeloma (transplant-eligible, KRd)
Dosage Information
KRd: Cycle 1 Days 1,2: 20mg/m² IV, then 27mg/m² Days 8,9,15,16. Cycle 2+: 27mg/m² Days 1,2,8,9,15,16 of 28-day cycle. Kd (ENDEAVOR): 56mg/m². Hydration required. Infuse over 10-30 min.
Always consult with a qualified healthcare professional for proper dosing. This information is for reference only.
Storage & Handling
Store at 2-8°C. Do not freeze. Reconstitute with 29mL SWFI (60mg vial). After reconstitution: stable 24h at 2-8°C or 4h at room temperature.
We ensure proper cold chain handling during shipping to maintain product integrity.
Full prescribing monograph
A single reference page compiled from the manufacturer's prescribing information and the regulator's public product data. No pricing is published on it.
Frequently Asked Questions About KYPROLIS
Find answers to common questions about ordering, pricing, and shipping.



